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PCardiac Resynchronization Therapy
The Utility of 12-Lead Holter Monitoring
in Patients With Permanent Atrial Fibrillation
for the Identification of Nonresponders
After Cardiac Resynchronization Therapy
Ganesh S. Kamath, MD, MPH, Delia Cotiga, MD, Jayanthi N. Koneru, MD,
Aysha Arshad, MD, Walter Pierce, MD, Emad F. Aziz, DO, Anisha Mandava, MD,
Suneet Mittal, MD, Jonathan S. Steinberg, MD
New York, New York
Objectives This study sought to determine the incidence of ineffective capture using 12-lead Holter monitoring and to as-
sess whether this affects response to cardiac resynchronization therapy (CRT).
Background Cardiac resynchronization therapy is used in patients with atrial fibrillation (AF), prolonged QRS duration, and
heart failure in the setting of ventricular dysfunction. The percentage of ventricular pacing is used as an indicator
of adequate biventricular (BiV) pacing. Although device counters show a high pacing percentage, there may be
ineffective capture because of underlying fusion and pseudo-fusion beats.
Methods We identified 19 patients (age 72  8 years, ejection fraction 18  5%), with permanent AF who underwent
CRT. All patients received digoxin, beta-blockers, and amiodarone for rate control; device interrogation showed
90% BiV pacing. Patients had a 12-lead Holter monitor to assess the presence of effective (90% fully paced
beats/24 h) pacing. At 12 months post-CRT, the New York Heart Association functional class was reassessed
and an echocardiogram was obtained and compared with pre-CRT.
Results Only 9 (47%) patients had effective pacing. The other 10 (53%) patients had 16.4  4.6% fusion and 23.5 
8.7% pseudo-fusion beats. Long-term responders (1 New York Heart Association functional class improvement)
to CRT had a significantly higher percentage of fully paced beats (86.4  17.1% vs. 66.8  19.1%; p  0.03)
than nonresponders.
Conclusions Pacing counters overestimate the degree of effective BiV pacing in patients with permanent AF undergoing CRT
therapy. Only patients with complete capture responded clinically to CRT. These findings have important implica-
tions for the application of CRT to patients with permanent AF and heart failure. (J Am Coll Cardiol 2009;53:
1050–5) © 2009 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.12.0222
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ptrial fibrillation (AF) frequently coexists with heart failure
HF), and its prevalence is closely related to the New York
eart Association (NYHA) functional class, with up to
rom the Al-Sabah Arrhythmia Institute and Division of Cardiology, St. Luke’s and
oosevelt Hospitals, Columbia University College of Physicians and Surgeons, New
ork, New York. Dr. Arshad is a consultant for St. Jude Medical and Lifewatch, and
as received speaking honoraria from Boston Scientific, Medtronic, and St. Jude
edical. Dr. Mittal is a consultant for Biotronik, Lifewatch, and Bard; has received
ellowship support from Boston Scientific, Medtronic, and St. Jude Medical; and has
eceived speaking honoraria from Boston Scientific, Medtronic, and St. Jude Medical.
r. Steinberg is a consultant for Boston Scientific, Lifewatch, and Sanofi-Aventis; has
eceived fellowship support from Boston Scientific, Medtronic, and St. Jude Medical;
as received speaking honoraria from Boston Scientific, Medtronic, St. Jude Medical,
nd Biotronik; and has received research support from Boston Scientific and
edtronic.s
Manuscript received May 26, 2008; revised manuscript received November 20,
008, accepted December 15, 2008.5% for class III and 50% for class IV HF (1). The
ermanent form of AF (2) is present in 10% to 30% of
atients with HF (3) and is associated with increased
orbidity and mortality (4,5).
Cardiac resynchronization therapy (CRT) has been in-
reasingly used to treat patients who have ejection fraction
35%, ventricular dyssynchrony (currently defined by a
RS duration 120 ms) and NYHA functional class III to
V HF. However, there are only limited clinical data on the
fficacy of CRT in patients with permanent AF, and the
vailable data to date have been inconsistent (6–9).
There is no possibility of response to CRT if ventricular
apture does not occur during biventricular (BiV) pacing. In
atients with HF and AF, there is no atrioventricular (AV)
ynchrony and BiV capture is difficult to ensure. The
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March 24, 2009:1050–5 12-Lead Holter in CRT Patients With AFercentage of BiV pacing alone as recorded by the CRT
evice may be an ineffective surrogate of complete and
onsistent BiV capture. Fusion and pseudo-fusion beats
esulting from an interaction between intrinsically con-
ucted and paced beats may be responsible for ineffective
acing, despite apparent delivery of CRT as assessed by a
igh percentage of BiV pacing (10). The objectives of this
tudy were: 1) to determine the incidence of effective and
neffective pacing, the latter defined by the presence of
usion and pseudo-fusion beats using a novel 12-lead Holter
nalysis, in patients with permanent AF who underwent
RT; and 2) to assess the effect of ineffective capture on
linical response in these patients.
ethods
atient selection. During an enrollment period of 18
onths, consecutive patients who underwent CRT were
creened for participation in the study. Informed written
onsent was obtained from all patients in the study, and the
rotocol was approved by our institutional review board.
nclusion criteria for the study included: age 18 years;
resence of permanent AF, defined as AF present for 1
ear in which no effort was made to restore sinus rhythm or
n which such efforts had previously failed; NYHA func-
ional class III/IV HF; left ventricular ejection fraction
LVEF) 35%; and QRS duration 120 ms. All patients
ere on optimal drug therapy for HF, which included
eta-blockers, angiotensin-converting enzyme inhibitors or
ngiotensin receptor blockers, diuretics, and spironolactone.
n addition, all patients were treated for rate control of AF
ith a beta-blocker, digoxin, and amiodarone. Amiodarone
as also used for suppression of ventricular arrhythmia, which
ould also interfere with pacing capture. Patients were excluded
f they had undergone atrioventricular junction (AVJ) ablation
or uncontrolled ventricular rates. The study cohort consisted
f patients who were documented to have a high degree
90%) of BiV pacing as documented by the device
ounters at follow-up post-CRT.
olter monitoring. At a median of 12 months after device
mplantation, patients were instructed to wear an ambula-
ory 12-lead Holter (ScottCare Corporation, Cleveland,
hio; formerly Rozinn Electronics) for 24 h. This 12-lead
olter monitor consisted of 6 chest wall leads, which were
laced in the standard manner, and limb electrodes, which
ere placed on the trunk close to arms and legs, correspond-
ng to a modified Mason-Likar lead configuration (11).
ata were stored on a digital flash card, with a capacity for
4-h recording. The system provided 20-bit resolution with
digital sampling rate of 180/s/lead for standard evaluation.
he data were transferred from the flash card to a computer
or analysis. Two electrophysiologists blinded to the identity
f the patient performed standard Holter analysis (heart
ate, RR interval, detection of supraventricular and ventric-
lar arrhythmia) using the Windows S version 10.01
ScottCare Corporation). In addition, a complete 12-lead tlectrocardiogram (ECG) was
btained and analyzed for the
hole period of 24 h.
Additional data that were col-
ected from the Holter monitor
ncluded percentage of fusion,
seudo-fusion, and complete
apture beats (using template-
atched analysis software). The
eartbeat waveforms were evalu-
ted within a fixed-length win-
ow around the fiducial points
100 ms before, 100 ms after).
he operator was required only
o initially select 3 normal heart-
eats (ventricular or paced com-
lexes) for each of the 12 leads
elected. These were named
riginal QRS templates, and
heir copies were substituted
ontinuously throughout the ECG analysis to capture slight
ariations in the heartbeat waveforms of the patient’s
ustained rhythm. The method is based on matching of the
valuated heartbeat with the QRS templates by a complex
et of ECG descriptors, including maximal cross-
orrelation, area difference, and frequency spectrum differ-
nce. The achieved unbiased accuracy is represented by
ensitivity of 98.4% and specificity of 98.8% (12).
A fusion beat was defined by the presence of a pacemaker
pike in the setting of a QRS complex with intermediate
orphology compared with a fully paced and native QRS
omplex. A pseudo-fusion beat was defined as a beat in
hich the pacemaker spike fell on top of an intrinsic beat.
he spike occurred, but played no part in depolarization,
herefore, no capture occurred and the QRS complex
eflected the morphology of the native QRS morphology.
ffective pacing was defined by the presence of more than
0% fully paced beats with complete capture of the heart as
onfirmed in all 12 leads.
evice implantation and programming. The right ven-
ricular lead was positioned in the right ventricular apex in
ll patients’ systems. Left ventricular lead placement was
uided by the intraoperative coronary sinus venogram; in all
ases, either a lateral or a posterolateral vein was selected for
ead implantation. All patients were programmed to ven-
ricular pacing mode. The lower pacing rate at implantation
as set at 70 beats/min. However, this could be altered at
ollow-up based on physician discretion. Seven patients had
uidant/Boston Scientific devices (Natick, Massachusetts),
1 had Medtronic devices (Minneapolis, Minnesota), and 1
ad a St. Jude Medical device (St. Paul, Minnesota)
mplanted. All Guidant devices had ventricular rate regu-
arization activated. In all Medtronic devices, ventricular
ense response and conducted AF response features were
ctivated. These algorithms are designed to maximize ven-
Abbreviations
and Acronyms
AF  atrial fibrillation
AV  atrioventricular
AVJ  atrioventricular
junction
BiV  biventricular
CRT  cardiac
resynchronization therapy
ECG  electrocardiogram
HF  heart failure
HR  hazard ratio
LVEF  left ventricular
ejection fraction
MR  mitral valve
regurgitation
NYHA  New York Heart
Associationricular pacing during potentially disruptive events such as
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rrhythmias.
easures of clinical outcome. Assessment of patient sta-
us was performed at 1, 3, 6, and 12 months after CRT. A
aseline echocardiographic examination had been per-
ormed according to American Society of Echocardiography
uidelines within 3 months preceding device implantation
er our routine laboratory protocol. The following param-
ters were collected in all patients: left ventricular end-
ystolic diameter, left ventricular end-diastolic diameter,
VEF, and degree of mitral valve regurgitation (MR). In
ddition, left ventricular end-systolic volume and left ven-
ricular end-diastolic volume were obtained in 15 patients;
n 4 patients the echocardiographic examination was per-
ormed on a machine that was not capable of rendering
ccurate volumetric data. The CRT device was interrogated
t all follow-up visits. The left ventricular pacing output was
djusted as needed to maintain adequate left ventricular
apture. Care was taken to evaluate for the presence of
entricular ectopy that could preclude 100% BiV pacing.
At 12 months, the NYHA functional class was reassessed
nd an echocardiogram was obtained; both were compared
ith the pre-CRT evaluation. An increase of 1 NYHA
unctional class was considered evidence of response to
RT. The echocardiograms before and after CRT were
nalyzed by an echocardiographer who was blinded to
evice programming parameters, Holter results, and infor-
ation regarding clinical response to CRT.
tatistical analysis. All continuous variables are expressed
s mean  SD. Categorical variables are summarized as
bsolute number and relative frequencies (%). Changes in
aseline Characteristics of Study Population (n  19)
Table 1 Baseline Characteristics of Study Population (n  19)
Clinical data
Age (yrs) 72 8
Male sex 12 (63%)
QRS duration (ms) 158 40
Heart rate (beats/min) 70 7
NYHA functional class III/IV 15/4
Etiology of cardiomyopathy
Ischemic 11 (58%)
Nonischemic 8 (42%)
Ejection fraction (%) 18 5
CRT device data
Biventricular capture (%) 95.4 3.2
Programmed lower pacing rate (ppm) 67.1 6.9
Programmed upper pacing rate (ppm) 116.8 8.8
RT cardiac resynchronization therapy; NYHA New York Heart Association; ppm pacing per
inute.
ata From 24-h 12-Lead Holter Recordings
Table 2 Data From 24-h 12-Lead Holter Recordings
Entire Group (n  19)
Fully paced beats (%/24 h) 76.1 20.3
Fusion beats (%/24 h) 9.8 7.9he before and after measurements were compared using the
onparametric Wilcoxon matched-pairs signed rank test.
he Mann-Whitney U test was used to compare the change
etween the 2 groups. The SPSS version 15.0 software
ackage (SPSS Inc., Chicago, Illinois) was used for the
tatistical analysis. Logistic regression analyses were used to
dentify univariate correlates of clinical response. Results
ith p  0.05 were considered statistically significant.
esults
total of 19 patients were enrolled in the study. The
linical characteristics of the patients and device settings are
ummarized in Table 1. The group was characterized by
evere left ventricular dysfunction, advanced HF, and long-
tanding AF.
olter findings. Overall, in this cohort, only 76% of the
eats were fully paced with complete capture, whereas
he remaining beats were ineffective. Further review of the
olter monitor results showed that only 9 (47%) patients
et criteria for effective pacing. The remaining 10 (53%)
atients met criteria for ineffective pacing; in these patients,
early 40% of pacing was accounted for fusion and pseudo-
usion (Table 2). Of the study group, 78% (7 of 9) of the
atients with effective pacing were responders, whereas 80%
8 of 10) of patients with noneffective pacing were nonre-
ponders (odds ratio: 3.9, 95% confidence interval [CI]: 1.1
o 14.1, p  0.023).
linical outcome and echocardiographic findings. There
ere no significant differences among responders and non-
esponders at baseline with respect to age, heart rate,
YHA functional class HF, or baseline echocardiographic
ata (Table 3).
During a median follow-up of 12 months, 47% of
atients showed evidence of clinical response. In addition to
n improvement in end-systolic dimension (0.75  0.9 cm
s. 0.2  0.5 cm; p  0.11) as compared with nonre-
ponders, responders had a significant improvement in
jection fraction (15.6% vs. 2.1%; p  0.02) and end-
iastolic diameter (0.9  0.8 cm vs. 0.2  0.2 cm; p 
.02). Responders had a greater reduction in the end-
ystolic volume (29.8  25.3% vs. 6.2  14.8%; p 
.07) and end-diastolic volume (16.8 13.8% vs.8.1
.2%; p 0.27) as compared with nonresponders (Table 3).
Review of the Holter data showed significant differences
etween responders and nonresponders (Table 3). Respond-
rs had a higher percentage of fully paced beats than
onresponders (86.4  17.1% vs. 66.8  19.1%; p  0.03).
n contrast, nonresponders had a significantly higher per-
ctive Paced Group (n  9) Noneffective Paced Group (n  10)
93.9 3.2 60.1 14.8
2.4 1.6 16.4 4.6Effe
Pseudo-fusion beats (%/24 h) 14.1 12.0 3.7 2.3 23.5 8.7
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March 24, 2009:1050–5 12-Lead Holter in CRT Patients With AFentage of ineffective pacing than responders because of a
ombination of fusion (13.3  6.7% vs. 5.9  7.6%; p 
.04) and pseudo-fusion (19.9 11.2% vs. 7.7 9.7%; p
.02) (Fig. 1). Ventricular ectopy was similar between
esponders and nonresponders and low because of chronic
miodarone therapy (ventricular premature beats/24 h 
7.3  25.1 vs. 20.0  26.7; p  0.8, nonsustained
entricular tachycardia runs/24 h  1.13  1.2 vs. 1.0 
.3, p  0.8).
Comparison of Responders and Nonresponders
Table 3 Comparison of Responders and Non
Respond
Age (yrs) 72
Heart rate (beats/min) 68
Pre-CRT NYHA functional class 3.3
Post-CRT NYHA functional class 1.7
Echocardiographic results
Baseline ejection fraction (%) 18.3
Baseline end-systolic diameter (cm) 4.9
Baseline end-systolic volume (ml) 119.4
Baseline end-diastolic diameter (cm) 6.3
Baseline end-diastolic volume (ml) 142.3
Baseline MR grade 2.7
Change in MR grade 1.0
Change in ejection fraction (%) 15.6
Change in end-systolic diameter (cm) 0.75
Change in end-systolic volume (%)* 29.8
Change in end-diastolic diameter (cm) 0.9
Change in end-diastolic volume (%)* 16.8
Holter data (%/24 h)
Fully paced beats 86.4
Fusion beats 5.9
Pseudo-fusion beats 7.7
*Data available in 15 patients: 6 responders, 9 nonresponders.
CRT  cardiac resynchronization therapy; MR  mitral regurgitatio
Figure 1 24-h Holter Data for Responders and Nonresponders
Responders had a higher percentage of fully paced beats than nonresponders
(p  0.03). Nonresponders had a significantly higher percentage of ineffective
pacing because of a combination of fusion (p  0.04) and pseudo-fusion (p 
0.02) beats.morrelates of clinical response. There was no significant
orrelation of age (hazard ratio [HR]: 1.0; 95% CI: 0.91 to
.14, p  0.8), sex (HR: 2.3; 95% CI: 0.34 to 16.2, p  0.4),
aseline heart rate (HR: 0.92; 95% CI: 0.79 to 1.06, p 0.23),
aseline LVEF (HR: 1.0; 95% CI: 0.85 to 1.2, p  0.9), or
YHA functional class (HR: 5.4; 95% CI: 0.44 to 66.6,
 0.2) with clinical response. The presence of 90% fully
aced beats was the only significant correlate of clinical
esponse (HR: 12.0; 95% CI: 1.3 to 111.3, p  0.03).
iscussion
ur study shows that the absolute percentage of BiV pacing
lone, as obtained from CRT device interrogation in patients
ith permanent AF, is an unreliable surrogate of effective
acing. Although CRT devices documented 90% pacing, in
ctuality fusion and pseudo-fusion beats constituted as much as
0% of the overall paced beats as determined by the use of a
2-lead Holter monitor. Thus, in patients with permanent AF
nd HF, using data from CRT counters alone to estimate
ercentage of BiV stimulation timemay bemisleading, because
ounters likely overestimate the degree of BiV pacing.
This study also confirms the importance of effective BiV
apture to ensure clinical response from CRT. Only effec-
ively paced patients showed a favorable clinical response
nd evidence of reverse remodeling after CRT. Previous
tudies have aimed for high percentages on CRT device
ounters to obtain adequate BiV capture. However, the
rogrammed percentages used in these studies have been
rbitrary (13). Rather than rely on the percentage pacing
nders
 9) Nonresponders (n  10) p Value
71 9 0.70
72 7 0.26
3.1 0.3 0.24
3.2 0.4 0.005
18.3 4.8 0.99
5.3 1.0 0.46
.6 102.4 38.6 0.19
6.5 0.5 0.41
.1 139.1 43.6 0.64
2.6 1.1 0.77
0.6 0.7 0.42
.6 2.1 9.9 0.02
0.2 0.5 0.11
.3 6.2 14.8 0.07
0.21 0.2 0.02
.8 8.1 7.2 0.27
.1 66.8 19.1 0.03
13.3 6.7 0.04
19.9 11.2 0.02
 New York Heart Association.respo
ers (n
 8
 7
 0.5
 0.5
 6.1
 0.4
 31
 0.7
 28
 0.8
 1.1
 12
 0.9
 25
 0.8
 13
 17
 7.6
 9.7easures obtained from the CRT device alone, we deter-
m
b
b
C
r
r
t
s
p
I
h
r
t
w
a
m
n
u
C
a
I
A
a
o
u
d
(
d
o
a
a
r
b
w
e
p
a
a
v
m
C
m
w
w
p
p
p
h
A
l
D
p
r
s
c
p
K
r
w
t
i
a
w
A
e
S
H
a
r
I
w
m
t
r
n
m
g
c
A
w
s
b
d
r
b
s
o
u
p
S
l
a
s
i
t
m
t
r
i
t
u
t
r
w
C
D
1054 Kamath et al. JACC Vol. 53, No. 12, 2009
12-Lead Holter in CRT Patients With AF March 24, 2009:1050–5ined the actual percentage of completely BiV captured
eats using a 12-lead Holter monitor. This concept has neither
een previously quantified nor correlated with outcome.
In studying patients who had a 90% BiV pacing from
RT devices, we selected a group that would be expected to
espond. We used the cutoff of 90% BiV pacing as
ecorded by CRT counters in all patients. Although arbi-
rary, this number was higher than that used in a previous
tudy (13) and it was reasonable to assume that this high
acing percentage would be adequate to achieve response.
mprovement in clinical response was instead explained by
igher percentage of paced beats with effective BiV capture,
ather than the simple counts of pacing delivery. In addi-
ion, reverse remodeling was shown only among responders
ith higher percentages of fully paced beats.
The management options for patient with permanent AF
nd HF include optimum rate control, cardioversion and
aintenance of sinus rhythm, or AVJ ablation with perma-
ent pacing. In patients in whom a rate control strategy is
sed, the best way to achieve rate control of AF for effective
RT remains unclear. This rate control may be difficult to
chieve during activity even in the presence of beta-blockers.
n patients with permanent AF who undergo CRT without
VJ ablation, few studies have suggested that cardioversion
nd aggressive rhythm control result in better clinical
utcomes (14,15). However, maintenance of sinus rhythm
sing antiarrhythmic drugs in the setting of AF and HF
oes not improve survival or other important end points
16), and maintenance of sinus rhythm will likely be very
ifficult in this setting. Because antiarrhythmic drugs are
nly partially effective in the maintenance of sinus rhythm
nd are associated with long-term adverse effects, catheter
blation may offer another approach for achieving sinus
hythm in these patients (17–19), but this approach has not
een tested in large number of patients. An AVJ ablation
ith insertion of a permanent pacemaker theoretically
nsures 100% ventricular capture. It renders the patient
acemaker dependent and forces consistent capture. This
pproach provides adequate rate control and also maintains
regular rhythm, thus providing additional benefit on
entricular function.
There are limited data from prior studies on the optimal
anagement of permanent AF and HF in patients receiving
RT. The MUSTIC (MUltisite STimulation in Cardio-
yopathies) trial showed similar improvement in the 6-min
alk test in class III HF patients after CRT whether they
ere in sinus rhythm or in AF (8). The study enrolled 64
atients, but only 37 patients completed both crossover
hases, limiting the impact of the results. In addition, all
atients with AF in the MUSTIC study were required to
ave a slow ventricular rate occurring spontaneously or after
VJ ablation. This may have selected patients who were
ikely to have a high degree of effective ventricular capture.
elnoy et al. (20) compared the efficacy of CRT in 96
atients with chronic AF and 167 patients with sinus
hythm. Overall mortality and rates of hospitalization were gimilar in both groups. However, among patients with
hronic AF, 22% had AVJ ablation and nearly 50% the
atients were in spontaneous or cardioverted sinus rhythm.
hadjooi et al. (21) studied 295 patients (209 in sinus
hythm, 66 in permanent AF, and 20 in paroxysmal AF)
ho underwent CRT therapy without AVJ ablation. Both
he AF and the sinus rhythm groups derived similar
mprovement in NYHA functional class, 6-min walk test,
nd quality-of-life scores. Echocardiographic improvements
ere also comparable. In patients with HF and permanent
F, rhythm regularization with AVJ ablation improved
xercise capacity and quality of life with BiV pacing (22).
imilarly, Gasparini et al. (13) showed that in patients with
F and permanent AF, only patients who underwent AVJ
blation showed a significant increase of ejection fraction,
everse remodeling effect, and improved exercise tolerance.
n contrast, no improvements were observed in AF patients
ho did not undergo AVJ ablation. The long-term effect on
ortality and hospitalizations was subsequently assessed in
he follow-up of 1,285 consecutive patients (1,042 in sinus
hythm, 243 in AF) who underwent CRT therapy (23). At
early 3 years of follow-up, all-cause mortality and cardiac
ortality were similar in the sinus rhythm group and the AF
roup. Within the AF group, total mortality was signifi-
antly better in the AVJ ablation group compared with the
F drug-treated group. These data suggest that patients
ith AF and HF may do better with the “ablate and pace”
trategy; however, this is not standard practice at this time
ecause this would create the large number of pacemaker-
ependent HF patients. In addition, a small but variable
ate of spontaneous conversion of AF to sinus rhythm has
een reported after CRT (24,25). The relatively low re-
ponse rate among patients with HF and permanent AF in
ur study suggests that regardless of the treatment method
sed, 100% effective BiV capture, rather than a high
ercentage of pacing, should be the goal.
tudy limitations. The relative small sample size is a
imitation of the study. Patients were enrolled consecutively
nd not randomized. The inclusion criteria for this study
pecified the stringent requirement of triple therapy includ-
ng amiodarone for optimal rate control, 90% BiV cap-
ure, and no AVJ ablation, and thus a group with maximal
edical management and presumably an optimized oppor-
unity to respond to CRT. Although responders and non-
esponders differed only in the percentage of effective and
neffective pacing, there may have been unmeasured factors
hat may have influenced response. Echocardiographic vol-
mes on all patients would have enabled the assessment of
he importance of full BiV capture to achieve reverse
emodeling. We cannot be certain whether our results
ould apply to other patients with AF, HF, and CRT.
onclusions
evice-based pacing counters overestimate the degree of
enuine effective BiV pacing in a significant number of
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March 24, 2009:1050–5 12-Lead Holter in CRT Patients With AFatients with permanent AF undergoing CRT therapy.
nly patients with a high percentage of demonstrated
omplete capture responded clinically to CRT or had
everse remodeling. Thus, the goal of CRT in these patients
s near 100% effective BiV capture as assessed on 12-lead
olter monitor, potentially achieved by medical therapy or
VJ ablation.
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